Advanced search
Publication Cover
International Journal of Radiation Biology Volume 90, 2014 - Issue 5
Submit an article Journal homepage
429
Views
59
CrossRef citations to date
0
Altmetric
IRON OXIDE NANOPARTICLES RADIOSENSITIZE CELLS

The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies

Samideh KhoeiCellular and Molecular Research Centre, School of Medicine, Iran University of Medical Sciences, Tehran, Iran;Medical Physics Department, School of Medicine, Iran University of Medical Sciences, Tehran, IranCorrespondence[email protected] [email protected]
,
Seied Rabi MahdaviMedical Physics Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Hamid FakhimikabirMedical Physics Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Ali Shakeri-ZadehMedical Physics Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
&
Abdolreza HashemianCanterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand;Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Pages 351-356 | Received 29 May 2013, Accepted 22 Jan 2014, Published online: 25 Feb 2014

References

  • Alkhatib A, Watanabe Y, Broadhurst JH. 2009. The local enhancement of radiation dose from photons of MeV energies obtained by introducing materials of high atomic number into the treatment region. Med Phys 36:3543–3548.
  • Cho SH. 2005. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Phys Med Biol 50:N163–173.
  • Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327
  • Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. 2007. What dose of external-beam radiation is high enough for prostate cancer?Int J Radiat Oncol Biol Phys 68: 682–689.
  • Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. 2008. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 60:977–985.
  • Huang FK, Chen WC, Lai SF, Liu CJ, Wang CL, Wang CH, Chen HH, Hua TE, Cheng YY, Wu MK, Hwu Y, Yang CS, Margaritondo G. 2010. Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles. Phys Med Biol 55:469–482.
  • Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, O’Sullivan JM, Hirst DG. 2011. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys 79:531–539.
  • Jones BL, Krishnan S, Cho SH. 2010. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med Phys 37:3809–3816.
  • Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regulat 41:189–207.
  • Mann A, Thakur G, Shukla V, Ganguli M. 2008. Peptides in DNA delivery: Current insights and future directions. Drug Discov Today 13:152–160.
  • McMahon SJ, Mendenhall MH, Jain S, Currell F. 2008. Radiotherapy in the presence of contrast agents: A general figure of merit and its application to gold nanoparticles. Phys Med Biol 53: 5635–5651.
  • Medarova Z, Pham W, Kim Y, Dai G, Moore A. 2006. In vivo imaging of tumor response to therapy using a dual-modality imaging strategy. Int J Cancer 118:2796–2802.
  • Nguyen PL, Zietman AL. 2007. High-dose external beam radiation for localized prostate cancer: Current status and future challenges. Cancer J 13:295–301.
  • Roeske JC, Nunez L, Hoggarth M, Labay E, Weichselbaum RR. 2007. Characterization of the theoretical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat 6:395–401.
  • Unger F, Wittmar M, Kissel T. 2007. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity. Biomaterials 28:1610–1619.
  • Walsh PC, DeWeese TL, Eisenberger MA. 2007. Clinical practice. Localized prostate cancer. New Eng J Med 357:2696–705.
  • Wardman P. 2007. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (Royal Coll Radiolog) 19:397–417.
  • Yih TC, Wei C. 2005. Nanomedicine in cancer treatment. Nanomedicine 1:191–192.
  • Zhang X, Xing JZ, Chen J, Ko L, Amanie J, Gulavita S, Pervez N, Yee D, Moore R, Roa W. 2008. Enhanced radiation sensitivity in prostate cancer by gold nanoparticles. Clin Investigat Med 31: E160–167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.